Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Denning DW and Warn P Dose range evaluation of liposomal nystatin and comparisons with amphotericin B and amphotericin B lipid complex in temporarily neutropenic mice infected with an isolate of Aspergillus fumigatus with reduced susceptibility to amphotericin B. 1999 Antimicrob. Agents Chemother. pmid:10543734
Clements-Jewery S Nystatin-induced potassium efflux from Saccharomyces cerevisiae measured by flame photometry: a potential bioassay approach. 1976 Antimicrob. Agents Chemother. pmid:773299
Lees ND et al. Azole susceptibility and hyphal formation in a cytochrome P-450-deficient mutant of Candida albicans. 1990 Antimicrob. Agents Chemother. pmid:2193620
Hsuchen CC and Feingold DS Selective membrane toxicity of the polyene antibiotics: studies on natural membranes. 1973 Antimicrob. Agents Chemother. pmid:4586145
González GM et al. In vitro activities of free and lipid formulations of amphotericin B and nystatin against clinical isolates of Coccidioides immitis at various saprobic stages. 2002 Antimicrob. Agents Chemother. pmid:11959606
Hsuchen CC and Feingold DS Selective membrane toxicity of the polyene antibiotics: studies on lecithin membrane models (liposomes). 1973 Antimicrob. Agents Chemother. pmid:4758835
Tevyashova AN et al. Structure-antifungal activity relationships of polyene antibiotics of the amphotericin B group. 2013 Antimicrob. Agents Chemother. pmid:23716057
Walker-Caprioglio HM et al. Antibodies to nystatin demonstrate polyene sterol specificity and allow immunolabeling of sterols in Saccharomyces cerevisiae. 1989 Antimicrob. Agents Chemother. pmid:2694950
Wasan KM et al. Physical characteristics and lipoprotein distribution of liposomal nystatin in human plasma. 1997 Antimicrob. Agents Chemother. pmid:9303376
Wallace TL et al. Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice. 1997 Antimicrob. Agents Chemother. pmid:9333054
Groll AH et al. Comparative drug disposition, urinary pharmacokinetics, and renal effects of multilamellar liposomal nystatin and amphotericin B deoxycholate in rabbits. 2003 Antimicrob. Agents Chemother. pmid:14638502
Retamales P et al. Complementation analysis with new genetic markers in Phaffia rhodozyma. 1998 Antonie Van Leeuwenhoek pmid:9801767
Kovalchik MT and Kraus SJ Neisseria gonorrhoeae: colonial morphology of rectal isolates. 1972 Appl Microbiol pmid:4624216
Patel PV and Johnston JR Dominant mutation for nystatin resistance in yeast. 1968 Appl Microbiol pmid:5636460
Huhtanen CN and Pensack JM Effect of antifungal compounds on aspergillosis in hatching chick embryos. 1967 Appl Microbiol pmid:5298442
Merkal RS and Richards WD Inhibition of fungal growth in the cultural isolation of mycobacteria. 1972 Appl Microbiol pmid:4561102
Plourde R and Hafez-Zedan H Distribution of steroid 1-dehydrogenation and side-chain degradation enzymes in the spores of Fusarium solani: causes of metabolic lag and carbohydrate independence. 1973 Appl Microbiol pmid:4699223
James AN et al. Variation in colonial morphology of Neisseria gonorrhoeae after growth on media containing antimicrobial agents. 1973 Appl Microbiol pmid:4201640
Wang W et al. The interaction of polysaccharide from Auricularia polytricha with quantum dots and the protection of plasmid DNA from damage. 2013 Appl. Biochem. Biotechnol. pmid:23440638
Sanchez S et al. Selective enrichment of aromatic amino acid auxotrophs in Hansenula polymorpha. 1978 Appl. Environ. Microbiol. pmid:345964
Volokhan O et al. Characterization of the P450 monooxygenase NysL, responsible for C-10 hydroxylation during biosynthesis of the polyene macrolide antibiotic nystatin in Streptomyces noursei. 2006 Appl. Environ. Microbiol. pmid:16597951
Nedal A et al. Analysis of the mycosamine biosynthesis and attachment genes in the nystatin biosynthetic gene cluster of Streptomyces noursei ATCC 11455. 2007 Appl. Environ. Microbiol. pmid:17905880
Gleeson MA et al. Isolation of Candida tropicalis auxotrophic mutants. 1990 Appl. Environ. Microbiol. pmid:2206102
Brautaset T et al. New nystatin-related antifungal polyene macrolides with altered polyol region generated via biosynthetic engineering of Streptomyces noursei. 2011 Appl. Environ. Microbiol. pmid:21764946
Kasbekar DP and Papavinasasundaram KG An inducible, nondegradative phytoalexin resistance mechanism in Dictyostelium discoideum is suppressed by mutations that alter membrane sterol composition. 1992 Appl. Environ. Microbiol. pmid:1622285
Shobayashi M et al. A new method for isolation of S-adenosylmethionine (SAM)-accumulating yeast. 2006 Appl. Microbiol. Biotechnol. pmid:16010571
Kim HJ et al. Redesign of antifungal polyene glycosylation: engineered biosynthesis of disaccharide-modified NPP. 2017 Appl. Microbiol. Biotechnol. pmid:28488115
Lee MJ et al. Structural analysis and biosynthetic engineering of a solubility-improved and less-hemolytic nystatin-like polyene in Pseudonocardia autotrophica. 2012 Appl. Microbiol. Biotechnol. pmid:22382166
Walmsley S et al. Engineered biosynthesis and characterisation of disaccharide-modified 8-deoxyamphoteronolides. 2017 Appl. Microbiol. Biotechnol. pmid:27858138
Fjaervik E and Zotchev SB Biosynthesis of the polyene macrolide antibiotic nystatin in Streptomyces noursei. 2005 Appl. Microbiol. Biotechnol. pmid:15700127
SPENCER MC CLINICAL LIMITATIONS OF EXPERIMENTAL CUTANEOUS MONILIASIS (CANDIDA ALBICANS). 1963 Arch Dermatol pmid:14071472
Coskey RJ Contact dermatitis due to nystatin. 1971 Arch Dermatol pmid:5552354
STONE OJ and MULLINS JF EXPERIMENTAL STUDIES ON CHRONIC PARONYCHIA. 1964 Arch Dermatol pmid:14096373
Stroud JD and Van Dersarl JV Striae. 1971 Arch Dermatol pmid:5539499
Cahill KM et al. Primary cutaneous aspergillosis. 1967 Arch Dermatol pmid:6054229
Rudolph N et al. Congenital cutaneous candidiasis. 1977 Arch Dermatol pmid:889338
White MI and Main RA The treatment of Hallopeau's acrodermatitis. 1979 Arch Dermatol pmid:426542
Marples RR et al. Topical steroid-antibiotic combinations: assay of use in experimentally induced human infections. 1973 Arch Dermatol pmid:4579498
Bradford LG and Montes LF Perioral dermatitis and Candida albicans. 1972 Arch Dermatol pmid:4555327
Tio TH et al. Subcutaneous phycomycosis. 1966 Arch Dermatol pmid:5940919
Garty BZ Stevens-Johnson syndrome associated with nystatin treatment. 1991 Arch Dermatol pmid:1827246
Coskey RJ and Bryan HG Letter: Contact dermatitis due to perfume in Mycolog cream. 1975 Arch Dermatol pmid:47237
Stritzler C Cutaneous candidiasis treated with topical amphotericin B. A comparative study. 1966 Arch Dermatol pmid:5900690
Chalmers D Letter: Subclinical infection. 1974 Arch Dermatol pmid:4852939
Maize JC and Lynch PJ Chronic mucocutaneous candidiasis of the adult. A report of a patient with an associated thymoma. 1972 Arch Dermatol pmid:5009626
Wasilewski C Allergic contact dermatitis from nystatin. 1971 Arch Dermatol pmid:5114421
Chalmers D Contact dermatitis due to nystatin. 1971 Arch Dermatol pmid:5114422
Coskey RJ and Paul L Ampicillin sensitivity in infectious mononucleosis. 1969 Arch Dermatol pmid:4312379
Porter PS and Lyle JS Yeast vulvovaginitis due to oral contraceptives. 1966 Arch Dermatol pmid:5862627
Petrozzi JW and Witkowski JA Acrodermatitis perstans. Generalization following therapy with nystatin. 1971 Arch Dermatol pmid:5091870
Crutcher N et al. Oral nystatin in the treatment of psoriasis. 1984 Arch Dermatol pmid:6703746
Wasilewski C Allergic contact dermatitis from nystatin. 1970 Arch Dermatol pmid:5430317
Carter VH and Olansky S Haloprogin and nystatin therapy for cutaneous candidiasis. Comparison of the efficacy of haloprogin and nystatin therapy. 1974 Arch Dermatol pmid:4608934
Ward DB et al. Characterization of diaper dermatitis in the United States. 2000 Arch Pediatr Adolesc Med pmid:10980800
Hernandez-Machin B et al. Picture of the month: diagnosis. 2007 Arch Pediatr Adolesc Med pmid:17768292
CARTER JJ et al. Nystatin in the control of fungous overgrowth during large bowel chemotherapy. 1960 Arch Surg pmid:13808034
Dyess DL et al. Candida sepsis. Implications of polymicrobial blood-borne infection. 1985 Arch Surg pmid:3970669
Desai MH et al. Candida infection with and without nystatin prophylaxis. A 11-year experience with patients with burn injury. 1992 Arch Surg pmid:1540092
Cerra FB et al. Selective gut decontamination reduces nosocomial infections and length of stay but not mortality or organ failure in surgical intensive care unit patients. 1992 Arch Surg pmid:1540093
Burchard KW et al. Fungal sepsis in surgical patients. 1983 Arch Surg pmid:6849638
Fryberg M et al. Sterol biosynthesis in antibiotic-resistant yeast: nystatin. 1974 Arch. Biochem. Biophys. pmid:4597559
KINSKY SC COMPARATIVE RESPONSES OF MAMMALIAN ERYTHROCYTES AND MICROBIAL PROTOPLASTS TO POLYENE ANTIBIOTICS AND VITAMIN A. 1963 Arch. Biochem. Biophys. pmid:14061721
Martin JB et al. 23Na NMR study of intracellular sodium ions in Dictyostelium discoideum amoeba. 1987 Arch. Biochem. Biophys. pmid:3579318
Fryberg M et al. Sterol biosynthesis in antibiotic sensitive and resistant Candida. 1976 Arch. Biochem. Biophys. pmid:769695
Kuo JF Stimulation of glucose utilization and inhibition of lipolysis by polyene antibiotics in isolated adipose cells. 1968 Arch. Biochem. Biophys. pmid:4301564
Strelling MK et al. Fatal acute pulmonary aspergillosis in two children of one family. 1966 Arch. Dis. Child. pmid:5324706
Howell A et al. Oral nystatin prophylaxis and neonatal fungal infections. 2009 Arch. Dis. Child. Fetal Neonatal Ed. pmid:19321509
Ganesan K et al. Prophylactic oral nystatin for preterm babies under 33 weeks' gestation decreases fungal colonisation and invasive fungaemia. 2009 Arch. Dis. Child. Fetal Neonatal Ed. pmid:19036756
Aydemir C et al. Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. 2011 Arch. Dis. Child. Fetal Neonatal Ed. pmid:20659937
Shahidi-Noghabi S et al. Internalization of Sambucus nigra agglutinins I and II in insect midgut CF-203 cells. 2011 Arch. Insect Biochem. Physiol. pmid:21254203
Premsingh N et al. Candida endocarditis in two patients. 1976 Arch. Intern. Med. pmid:1108825
Jones PG et al. Efficacy of ketoconazole v nystatin in prevention of fungal infections in neutropenic patients. 1984 Arch. Intern. Med. pmid:6322710
Mitus WJ et al. Abnormal (marker) chromosomes in two patients with acute myelofibrosis. 1969 Arch. Intern. Med. pmid:5763618
Toala P et al. Candida at Boston City Hospital. Clinical and epidemiological characteristics and susceptibility to eight antimicrobial agents. 1970 Arch. Intern. Med. pmid:5483601
Borgos SE et al. Effect of glucose limitation and specific mutations in the module 5 enoyl reductase domains in the nystatin and amphotericin polyketide synthases on polyene macrolide biosynthesis. 2006 Arch. Microbiol. pmid:16416127
Kowalski RP et al. Antifungal synergism. A proposed dosage for corneal storage medium. 1985 Arch. Ophthalmol. pmid:3872116
BONATTI WD et al. ENDOGENOUS FUNGAL ENDOPHTHALMITIS. CLINICAL COURSE IN A SUCCESSFULLY TREATED CASE. 1963 Arch. Ophthalmol. pmid:14061741
Mayercik VA et al. Fungal endophthalmitis developing in asthmatic individuals treated with inhaled corticosteroids. 2011 Arch. Ophthalmol. pmid:21746988
Polack FM et al. Keratomycosis. Medical and surgical treatment. 1971 Arch. Ophthalmol. pmid:4929071
Green WR et al. Asperillosis of the orbit. Report of ten cases and review of the literature. 1969 Arch. Ophthalmol. pmid:5806054
O'Day DM et al. Deep fungal corneal abscess. Combined corticosteroid therapy. 1971 Arch. Ophthalmol. pmid:4938789
Bell RW and Ritchey JP Subconjunctival nodules after amphotericin B injection. Medical therapy for Aspergillus corneal ulcer. 1973 Arch. Ophthalmol. pmid:4126867
Scheibler E et al. Stability and efficacy of combined nystatin and chlorhexidine against suspensions and biofilms of Candida albicans. 2018 Arch. Oral Biol. pmid:29477025
Curvelo JA et al. Effect of the secretory leucocyte proteinase inhibitor (SLPI) on Candida albicans biological processes: a therapeutic alternative? 2014 Arch. Oral Biol. pmid:24907522
Peixoto LR et al. Antifungal activity, mode of action and anti-biofilm effects of Laurus nobilis Linnaeus essential oil against Candida spp. 2017 Arch. Oral Biol. pmid:27771586
Nikawa H et al. The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin. 1994 Arch. Oral Biol. pmid:7741664
Ellepola AN and Samaranayake LP Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents. 1998 Arch. Oral Biol. pmid:9877331
Dorocka-Bobkowska B et al. Influence of antifungal polyenes on the adhesion of Candida albicans and Candida glabrata to human epithelial cells in vitro. 2003 Arch. Oral Biol. pmid:14596870
El-Hawash SA et al. Synthesis of some new quinoxalines and 1,2,4-triazolo[4,3-a]-quinoxalines for evaluation of in vitro antitumor and antimicrobial activities. 2006 Arch. Pharm. (Weinheim) pmid:17009301
Mete E et al. Synthesis and antifungal activity of 1-aryl-3-phenethylamino-1-propanone hydrochlorides and 3-aroyl-4-aryl-1-phenethyl-4-piperidinols. 2010 Arch. Pharm. (Weinheim) pmid:20232370
Ruzicková J and Parrák V [Determination of the sterility of nystatin and Natamycin by UV spectrophotometry (author's transl)]. 1982 Arch. Pharm. (Weinheim) pmid:6981393
Elmegeed GA et al. Synthesis and antimicrobial evaluation of some novel cholestane heterocyclic derivatives. 2004 Arch. Pharm. (Weinheim) pmid:15038058
Sakeer K et al. Enhancement of dissolution of nystatin from buccoadhesive tablets containing various surfactants and a solid dispersion formulation. 2010 Arch. Pharm. Res. pmid:21116780
Weissmann G et al. Arthritis induced by filipin in rabbits. 1967 Arthritis Rheum. pmid:4227672
Polatti F et al. Clinical study on the dose-effect relationship of a nifuratel-nystatin combination in the treatment of vulvo-vaginal infections. 2003 Arzneimittelforschung pmid:14650366
Goldstein DJ et al. Fungal infections in left ventricular assist device recipients. Incidence, prophylaxis, and treatment. 1995 Oct-Dec ASAIO J. pmid:8589469
Pérez Prim FJ and Vila I [Ongoing treatment with omeprazole and appearance of oropharyngeal candidiasis]. 2002 Aten Primaria pmid:12525346
Bastiaan RJ Denture sore mouth. Aetiological aspects and treatment. 1976 Aust Dent J pmid:797370
Quirk PC et al. Australian Dental Research Fund Trebitsch Scholarship. Efficacy of antifungal prophylaxis in bone marrow transplantation. 1995 Aust Dent J pmid:7575286
Dennerstein GJ and Langley R Vulvovaginal candidiasis: treatment and recurrence. 1982 Aust N Z J Obstet Gynaecol pmid:6963163